Difference between revisions of "Team:UCC Ireland"

(Undo revision 350598 by Paulr93 (talk))
Line 1: Line 1:
  
−
 
+
<html lang="en">
−
<html lang="en" xmlns="http://www.w3.org/1999/html">
+
 
   <head>
 
   <head>
 
     <meta charset="utf-8">
 
     <meta charset="utf-8">
Line 8: Line 7:
 
     <!-- The above 3 meta tags *must* come first in the head; any other head content must come *after* these tags -->
 
     <!-- The above 3 meta tags *must* come first in the head; any other head content must come *after* these tags -->
  
−
     <title>UCC iGEM</title>
+
     <title>Starter Template for Bootstrap</title>
  
−
    <!-- Bootstrap core CSS -->
+
     <link href="https://maxcdn.bootstrapcdn.com/font-awesome/4.6.3/css/font-awesome.min.css" type="text/css" rel="stylesheet">
−
     <link rel="stylesheet" href="https://2016.igem.org/Team:UCC_Ireland/main.css?action=raw&amp;ctype=text/css">
+
     <link rel="stylesheet" href="https://2016.igem.org/Template:Team:UCC_Ireland/CSS?action=raw&amp;ctype=text/css">
−
    <link rel="stylesheet" href="https://2016.igem.org/Team:UCC_Ireland/font-awesome.css?action=raw&amp;ctype=text/css">
+
−
     <link rel="stylesheet" href="https://2016.igem.org/Team:UCC_Ireland/bootstrap.css?action=raw&amp;ctype=text/css">
+
 
      
 
      
 
   </head>
 
   </head>
Line 28: Line 25:
 
               <span class="icon-bar"></span>
 
               <span class="icon-bar"></span>
 
             </button>
 
             </button>
−
              <a class="navbar-brand" href="#"><img style="height: 80px;" src="img/LIMITLESSLACTIS-WHITE.png" alt=""></a>
+
            <a class="navbar-brand" href="#"><img style="height: 64px;" src="https://static.igem.org/mediawiki/2016/3/3d/T--UCC_Ireland--Seema_-_Final.png" alt=""></a>
 
           </div>
 
           </div>
 
           <div id="navbar" class="navbar-collapse collapse">
 
           <div id="navbar" class="navbar-collapse collapse">
Line 34: Line 31:
 
               <li class="active"><a href="#">Home</a></li>
 
               <li class="active"><a href="#">Home</a></li>
 
               <li><a href="project.html">Project</a></li>
 
               <li><a href="project.html">Project</a></li>
−
               <li class="dropdown">
+
               <li><a href="outreach.html">Outreach</a></li>
−
                <a class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Outreach<span class="caret"></span></a>
+
−
                <ul class="dropdown-menu">
+
−
                  <li><a href="silver.html">HP Silver</a></li>
+
−
                  <li><a href="gold.html">HP Gold</a></li>
+
−
                  <li role="separator" class="divider"></li>
+
−
                  <li><a href="application-scenario.html">Engagement</a></li>
+
−
                  <li><a href="techno-moral-scenario.html">Integrated Practices</a></li>
+
−
                </ul>
+
−
              </li>
+
 
               <li><a href="team.html">Team</a></li>
 
               <li><a href="team.html">Team</a></li>
 
               <li><a href="notebook.html">Notes</a></li>
 
               <li><a href="notebook.html">Notes</a></li>
 
               <li><a href="parts.html">Parts</a></li>
 
               <li><a href="parts.html">Parts</a></li>
−
               <li class="dropdown">
+
               <li><a href="collaborations.html">Collaborations</a></li>
−
                <a class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Collaborations <span class="caret"></span></a>
+
               <li><a href="interlab_study">Interlab</a></li>
−
                <ul class="dropdown-menu">
+
−
                  <li><a href="collaborations.html">iGEM Teams</a></li>
+
−
                  <li role="separator" class="divider"></li>
+
−
                  <li class="dropdown-header">Synenergene</li>
+
−
                  <li><a href="application-scenario.html">Application Scenario</a></li>
+
−
                  <li><a href="techno-moral-scenario.html">Techno-Moral Scenario</a></li>
+
−
                </ul>
+
−
              </li>
+
−
               <li><a href="interlab_study.html">Interlab</a></li>
+
 
               <li><a href="achievements.html">Achievements</a></li>
 
               <li><a href="achievements.html">Achievements</a></li>
 
               <li><a href="attributions.html">Attributions</a></li>
 
               <li><a href="attributions.html">Attributions</a></li>
Line 64: Line 43:
 
         </div>
 
         </div>
 
       </nav>
 
       </nav>
−
       <div class="container-fluid fix-nav-padding-top">
+
       <div class="container-fluid" id="home">
  
 
         <div class="row" id="landing">
 
         <div class="row" id="landing">
 
           <div class="col-xs-12 col-md-12">
 
           <div class="col-xs-12 col-md-12">
−
 
+
            <h1 class="text-uppercase text-center">Limitless Lactis</h1>
 +
            <p class="lead text-center">Intelligent <em>Lactococcus lactis</em> strains as a protein delivery platform for disease treatment.</p>
 
              
 
              
−
             <img class="img-circle" style="width: 350px; display:block; margin:auto;" src="img/LIMITLESSLACTIS-BLACK.png" alt="">
+
             <img style="width: 230px; display:block; margin:auto;" src="https://static.igem.org/mediawiki/2016/3/3d/T--UCC_Ireland--Seema_-_Final.png" alt="">
 
             <p class="lead text-center" style="padding: 10px;">
 
             <p class="lead text-center" style="padding: 10px;">
 
               <a class="btn btn-primary btn-lg" href="#" role="button">Learn more</a>
 
               <a class="btn btn-primary btn-lg" href="#" role="button">Learn more</a>
Line 83: Line 63:
 
         <div class="row text-center" id="abstract">
 
         <div class="row text-center" id="abstract">
 
           <div class="col-xs-12 col-md-8 col-md-offset-2">
 
           <div class="col-xs-12 col-md-8 col-md-offset-2">
−
             <h2 class="text-center"><span>Limitless Lactis:</span> Intelligent <em>Lactococcus lactis</em> strains as a protein delivery platform for disease treatment.</h2>
+
             <h2 class="text-uppercase">Abstract</h2>
−
    <hr>
+
            <p class="lead text-left">
−
              <p class="lead text-left">
+
 
               <em>Lactococcus lactis</em>, a generally recognised as safe (GRAS) bacterium commonly used in food production, is highly amenable to genetic manipulation. We aim to develop a synthetic L. lactis-based platform that can deliver proteins to immune cells to precisely influence the host immune response for use in the treatment of various diseases. Potential applications which we have investigated include vaccination strategies and macrophage modification. We have developed the platform as a vaccine against leishmaniasis, a neglected tropical disease increasing in geographical distribution. LJM11 is an immunogenic salivary protein of the sandfly vector, Lutzomyia longipalpis. Our inexpensive platform, through simple oral administration, has the capacity to deliver this protein to antigen-presenting cells, and potentially immunise against the life cycle of leishmaniasis. Besides vaccination strategies, this platform may be employed to modify the phenotype of other phagocytic cells associated with diseases such as cancer.
 
               <em>Lactococcus lactis</em>, a generally recognised as safe (GRAS) bacterium commonly used in food production, is highly amenable to genetic manipulation. We aim to develop a synthetic L. lactis-based platform that can deliver proteins to immune cells to precisely influence the host immune response for use in the treatment of various diseases. Potential applications which we have investigated include vaccination strategies and macrophage modification. We have developed the platform as a vaccine against leishmaniasis, a neglected tropical disease increasing in geographical distribution. LJM11 is an immunogenic salivary protein of the sandfly vector, Lutzomyia longipalpis. Our inexpensive platform, through simple oral administration, has the capacity to deliver this protein to antigen-presenting cells, and potentially immunise against the life cycle of leishmaniasis. Besides vaccination strategies, this platform may be employed to modify the phenotype of other phagocytic cells associated with diseases such as cancer.
 
             </p>
 
             </p>
−
              <hr>
 
−
              <div class="embed-responsive embed-responsive-16by9">
 
−
                  <iframe class="embed-responsive-item" src="https://www.youtube.com/embed/Dga9zislKtI"></iframe>
 
−
              </div>
 
 
           </div>
 
           </div>
 
         </div><!-- /abstract -->
 
         </div><!-- /abstract -->
Line 97: Line 72:
 
         <br>
 
         <br>
 
         <br>
 
         <br>
 +
        <a href="2016.igem.org/Team:UCC_Ireland/bootstrap.css">boostrap.css</a>
 +
        <a href="2016.igem.org/Team:UCC_Ireland/font-awesome.css">font-awesome.css</a>
 
         <br>
 
         <br>
 
         <hr>
 
         <hr>
Line 104: Line 81:
 
             <div class="row">
 
             <div class="row">
 
               <div class="col-xs-2 col-md-1">
 
               <div class="col-xs-2 col-md-1">
−
                 <img src="img/sponsors/ccrc.png" alt="">
+
                 <img src="img/ccrclogoeditkev.png" alt="">
 +
              </div>
 +
              <div class="col-xs-2 col-md-1">
 +
                <img src="img/COMH.jpg" alt="">
 
               </div>
 
               </div>
 
               <div class="col-xs-2 col-md-1">
 
               <div class="col-xs-2 col-md-1">
−
                 <img src="img/sponsors/COMH.jpg" alt="">
+
                 <img src="img/Fyffes_SVG_logo.svg.png" alt="">
 
               </div>
 
               </div>
 
               <div class="col-xs-2 col-md-1">
 
               <div class="col-xs-2 col-md-1">
−
                 <img src="img/sponsors/Fyffes_SVG_logo.svg.png" alt="">
+
                 <img src="img/genscripteditkevin.png" alt="">
 
               </div>
 
               </div>
 
               <div class="col-xs-2 col-md-1">
 
               <div class="col-xs-2 col-md-1">
−
                 <img src="img/sponsors/genscripteditkevin.png" alt="">
+
                 <img src="img/IDT_logo_trans.png" alt="">
 
               </div>
 
               </div>
 
               <div class="col-xs-2 col-md-1">
 
               <div class="col-xs-2 col-md-1">
−
                 <img src="img/sponsors/IDT_logo_trans.png" alt="">
+
                 <img src="img/logo (1).png" alt="">
 
               </div>
 
               </div>
 
               <div class="col-xs-2 col-md-1">
 
               <div class="col-xs-2 col-md-1">
−
                 <img src="img/sponsors/logo (1).png" alt="">
+
                 <img src="img/ccrclogoeditkev.png" alt="">
 
               </div>
 
               </div>
 
               <div class="col-xs-2 col-md-1">
 
               <div class="col-xs-2 col-md-1">
−
                 <img src="img/sponsors/schoolofbiochemlogoeditkevin.png" alt="">
+
                 <img src="img/COMH.jpg" alt="">
 
               </div>
 
               </div>
 
               <div class="col-xs-2 col-md-1">
 
               <div class="col-xs-2 col-md-1">
−
                 <img src="img/sponsors/apc.png" alt="">
+
                 <img src="img/Fyffes_SVG_logo.svg.png" alt="">
 
               </div>
 
               </div>
 
               <div class="col-xs-2 col-md-1">
 
               <div class="col-xs-2 col-md-1">
−
                 <img src="img/sponsors/genscripteditkevin.png" alt="">
+
                 <img src="img/genscripteditkevin.png" alt="">
 
               </div>
 
               </div>
 
               <div class="col-xs-2 col-md-1">
 
               <div class="col-xs-2 col-md-1">
−
                 <img src="img/sponsors/IDT_logo_trans.png" alt="">
+
                 <img src="img/IDT_logo_trans.png" alt="">
 
               </div>
 
               </div>
 
               <div class="col-xs-2 col-md-1">
 
               <div class="col-xs-2 col-md-1">
−
                 <img src="img/sponsors/logo (1).png" alt="">
+
                 <img src="img/logo (1).png" alt="">
 
               </div>
 
               </div>
 
             </div>
 
             </div>

Revision as of 20:39, 18 October 2016

Starter Template for Bootstrap

Limitless Lactis

Intelligent Lactococcus lactis strains as a protein delivery platform for disease treatment.

Learn more

Abstract

Lactococcus lactis, a generally recognised as safe (GRAS) bacterium commonly used in food production, is highly amenable to genetic manipulation. We aim to develop a synthetic L. lactis-based platform that can deliver proteins to immune cells to precisely influence the host immune response for use in the treatment of various diseases. Potential applications which we have investigated include vaccination strategies and macrophage modification. We have developed the platform as a vaccine against leishmaniasis, a neglected tropical disease increasing in geographical distribution. LJM11 is an immunogenic salivary protein of the sandfly vector, Lutzomyia longipalpis. Our inexpensive platform, through simple oral administration, has the capacity to deliver this protein to antigen-presenting cells, and potentially immunise against the life cycle of leishmaniasis. Besides vaccination strategies, this platform may be employed to modify the phenotype of other phagocytic cells associated with diseases such as cancer.




boostrap.css font-awesome.css